Ultragenyx Pharmaceutical Cash Conversion Cycle 2011-2026 | RARE

Annual Cash Conversion Cycle Ultragenyx Pharmaceutical

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
75.9	63.7	47.9	34.6	26.8	37.7	80.2	-2.06 K	-2.46 M	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
80.2	-2.46 M	-274 K

Quarterly Cash Conversion Cycle Ultragenyx Pharmaceutical

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	32.4	-	28	26.1	22.1	23	25.9	34.1	70.3	84.2	116	-33.7	-545	71.5	-1.64 K	-3.28 K	-2.63 K	196	2.38 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.38 K	-3.28 K	-279

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	3.11 K	-	5743.5 %	$ 69.7 M	Canada
Happiness Biotech Group Limited HAPP	-3.12 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
AstraZeneca PLC AZN	-58	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Esperion Therapeutics ESPR	99.7	$ 3.14	0.32 %	$ 653 M	USA
Eton Pharmaceuticals ETON	115	$ 35.52	3.11 %	$ 956 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Celyad Oncology SA CYAD	-55.7 K	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	214	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	47.6	-	-	$ 344 M	USA
Grifols, S.A. GRFS	0.000171	$ 8.15	-0.55 %	$ 5.54 B	Spain
Autolus Therapeutics plc AUTL	119	$ 1.67	3.09 %	$ 444 M	Britain
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Heron Therapeutics HRTX	751	$ 0.88	3.99 %	$ 147 M	USA
Cyclacel Pharmaceuticals CYCCP	-1.6 K	-	-4.36 %	$ 27 M	USA
Compugen Ltd. CGEN	-82.7	$ 2.66	-1.85 %	$ 249 M	Israel
Anika Therapeutics ANIK	192	$ 15.15	0.07 %	$ 217 M	USA
Advaxis ADXS	-82.3 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
Applied Genetic Technologies Corporation AGTC	126	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-1.92	-	1.93 %	$ 17.4 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Coherus BioSciences CHRS	149	$ 1.59	5.43 %	$ 186 M	USA
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Arcutis Biotherapeutics ARQT	158	$ 20.95	2.34 %	$ 2.67 B	USA
Ampio Pharmaceuticals AMPE	-4.62 K	-	-11.43 %	$ 502 K	USA